GMERS MEDICAL COLLEGE, DHARPUR, PATAN, TIME TABLE OF

SR.NO. DATE DAY 9-10am 10-11am 11-12noon 12-1pm 2-3pm 3-5pmHorizontal Vertical

101/03/2021 Monday

L-Pathology PA 1.2 Describe the history

and evolution of Pathology

L-FMT INTRODUCTION & HISTORY-1

FM 1.1,1.2 SGD-PSM(CM3:6/3.7/3.8 Entomology I)

2

02/03/2021 Tuesday

L-Pharmacology DEFINATION OF

GENERAL PHARMACOLOGY,

TERMINOLOGIES & SOURCES OF DRUGS

PH 1.1, 1.9

L-Pathology PA 1.3 Enumerate common

definitions and terms used in Pathology

P-Pharmacology(A+B)INTRODUCTION TO

PRACTICAL PHARMACOLOGY AND

TERMINOLOGIES PH 1.1/ Pathology(C+D)-

Microscopy and collection of blood

3

03/03/2021 WednesdayL-Microbiology MI1.1 Introduction -

Microbiology

L-Pharmacology PHARMACOKINETICS:

ABSORPTION AND DISTRIBUTION OF DRUGS PH

1.4

P-Pharmacology(C+D)INTRODUCTION TO

PRACTICAL PHARMACOLOGY AND

TERMINOLOGIES PH 1.1/ Pathology(A+B)-

Microscopy and collection of blood

4

04/03/2021 Thursday

L-Pathology-Describe the history and

evolution of Pathology & Enumerate

common definitions and terms used in

Pathology (PA 1.2 TO 1.3)

SGD-Pharmacology (A+B)BIOTRANSFORMATION

OF DRUGS PH 1.4/Pathology C+D PA 1.1 Descibe

the role of pathologist in diagnosis and

management if disease

P-Microbiology Microbial World

MI1.1,Biosafety and Universal Precaution

MI8.7(A+B)/FMT(C+D)(Genral Toxicology-

1)FM 8.1-8.5

5

05/03/2021 FridayL-Microbiology MI1.1 History of

Microbiology

SGD-Pharmacology(C+D)BIOTRANSFORMATION

OF DRUGS PH 1.4/Pathology A+B PA 1.1 Descibe

the role of pathologist in diagnosis and

management if disease

P-MicrobiologyMicrobial World

MI1.1,Biosafety and Universal Precaution

MI8.7(C+D)/FMT(A+B)(Genral Toxicology-

1)FM 8.1-8.5

6

6/3/-2021 Saturday L-Medicine l-Surgery L-Obs & gynec

SDL-Pharmacology(A+B)/ Pathology(C+D)

Study on Corona Virus ROUTES OF DRUG

ADMINISTRATION PH 1.11

707/03/2021 Sunday

8

08/03/2021 Monday

L- Pathology-Demonstrate knowledge of

the causes, mechanisms, types and

effects of cell injury and

their clinical significance (PA 2.1)

L-PSM(CM5.3,Define and describe common

nutrition related health disorders (including

macro-PEM, Micro-iron, Zn, iodine, Vit. A)

SGD-Micrbiology Infectious diseases -

Epidemiology MI1.3 /PSM(CM3.6/3.7/3.8

Entomology II)

9

09/03/2021 Tuesday Pharmacology EXCRETION PH 1.4

Pathology-Describe the etiology of cell injury.

Distinguish between reversible-irreversible

injury:

mechanisms; morphology of cell injury(PA 2.2)

Pharmacology(A+B)OVERVIEW OF PRACTICAL

JOURNAL,LOG BOOK AND EXPLANATION OF

LOG BOOK ASSESSMENT/

Pathology(C+D)Hemoglobin estimation

(PY2.11)

10

10/03/2021 WednesdayMicrobiology MI1.1 Introduction -

Viruses - 1 - Morphology & Classification

Pharmacology PHARMACODYNAMIC 1:

PRINCIPLES AND MECHANISM OF DRUG ACTION

PH 1.5

Pharmacology(C+D)OVERVIEW OF PRACTICAL

JOURNAL,LOG BOOK AND EXPLANATION OF

LOG BOOK ASSESSMENT/

Pathology(A+B)Hemoglobin estimation

(PY2.11)

1111/03/2021 Thursday

12

12/03/2021 Friday

Microbiology MI1.1 Introduction -

Bacteria - 1 - Nomenclature &

Classification

SGD-Pharmacology (C+D)CLINICAL APPLICATION

OF PHARMACOKINETICS PH 1.4

/Pathology A+B Describe and discuss cellular

adaptations: atrophy, hypertrophy, hyperplasia,

metaplasia, dysplasia PA 2.6

MICOBIOLOGY PRACTICALBasic Microscopy

MI1.2 MicroscopyMI1.2

C+D/FMT(A+B)(Genral Toxicology-1)FM 8.1-

8.5

13

13/3/2021 Saturday L-Medicine l-Surgery L-Obs & gynec

SDL-Pharmacology(C+D)/ Pathology(A+B)

Study on Corona Virus ROUTES OF DRUG

ADMINISTRATION PH 1.11

1414/3/2021 Sunday

15

15/3/2021 Monday

L-Pathology-Intracellular accumulation of

fats, proteins, carbohydrates, pigments

(PA 2.3)

L-FMT INTRODUCTION & HISTORY-2

FM 1.1,1.2 SGD-PSM(CM4.1Health Education)

Integration

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

SPORTS & EXTRACURRICULLAR ACTIVITIES

NA

Clinical Posting

Clinical Posting

Clinical Posting-PSM(CM5.2,5.7,DIETARY SURVEY METHODS, FOOD HYGIENE)

Holiday-Shivratri

Clinical Posting-PSM(CM5.2,NUTRITIONAL ASSESSMENT METHODS)


NA

Clinical Posting

GMERS MEDICAL COLLEGE, DHARPUR, PATAN, TIME TABLE OF SYMBBS BATCH 2020-2021

16

16/3/2021 TuesdayL-Pharmacology-RECEPTOR MEDIATED

DRUG ACTION PH 1.5

L-Pathology-Describe and discuss Cell death-

types, mechanisms, necrosis, apoptosis( basic as

contrast with necrosis),autolysis(PA 2.4)

P-Pharmacology(A+B)INTRODUCTION TO

CLINICAL PHARMACY PH 1.59, 1.63/

Pathology(C+D)Haemocytometer and red Cell

count(PY2.11)

17


Bacteria - 2 - Morphology & Physiology

L-PharmacologyFACTORS MODIFYING DRUG

ACTION PH 1.5

P-Pharmacology(C+D)INTRODUCTION TO

CLINICAL PHARMACY PH 1.59, 1.63/

Pathology(A+B)Haemocytometer and red Cell

count(PY2.11)

18

18/3/2021 Thursday

L-Pathology-Describe and discuss the

mechanisms of cellular aging and

apoptosis(PA 2.7)

SGD-Pharmacology (A+B)CLINICAL APPLICATION

OF PHARMACOKINETICS PH 1.4/Pathology C+D

Describe and discuss cellular adaptations:

atrophy, hypertrophy, hyperplasia, metaplasia,

dysplasia PA 2.6

P-Microbiology Basic Microscopy MI1.2

MicroscopyMI1.2(A+B)/FMT(C+D)GENERAL

TOXICOLOGY -2

FM 8.6-8.10,

19

19/3/2021 FridayL-Microbiology MI1.6 Bacterial Genetics

& Basis of Drug Resistance

SGD-Pharmacology/Pathology A+BADVERSE

DRUG INTERACTION PH 1.7 PA 3.1-Describe the

pathogenesis and pathology of amyloidosis

PA 3.2-Identify and describe amyloidosis in a

pathology specimen

P-Microbiology Introduction - Viruses - 2 -

Laboratory Diagnosis

MI1.1(C+D)/FMT(A+B)GENERAL TOXICOLOGY -

2

FM 8.6-8.10


SDL-Microbiology MI 1.6 Drug

Resistance(A+B)/PSM (C+D)

2121/3/2021 Sunday

22

22/3/2021 Monday

L-Pathology-Describe and discuss

pathologic calcifications, gangrene(PA

2.5)

L-PSM(CM5.4,Define and describe common

nutrition related health disorders (including

macro-PEM, Micro-iron, Zn, iodine, Vit. A), their

control and management)

SGD-PSM(CM6.2,Describe and discuss the

principles and demonstrate the methods of

classification and presentation of statistical

data)

23

23/3/2021 Tuesday

L-Pharmacology DOSE RESPONSE

RELATIONSHIP: EFFICACY, POTENCY AND

ANTAGONISM PH 1.5

L-Pathology-Define and describe the general

features of acute and chronic inflammation

including

stimuli, vascular and cellular events(PA 4.1)(VI-

GS)

P-Pharmacology(A+B)ORAL ROUTE OF DRUG

ADMINISTRATION PH 2.1/

Pathology(C+D)Haemotocrit, Red cell

Indices& Reticulocyte count(PY2.11-2.13)

Patho-General Surgery

24


Fungi - 1 - Classification

L-Pharmacology SYNTHESIS, STORAGE, RELEASE

OF SYMPATHETIC NEUROTRANSMITTERS AND

DRUGS ACTING ON IT PH 1.13

P-Pharmacology(C+D)ORAL ROUTE OF DRUG

ADMINISTRATION PH 2.1/

Pathology(A+B)Haemotocrit, Red cell

Indices& Reticulocyte count(PY2.11-2.13)

25

25/3/2021 Thursday

L-Pathology-Enumerate and describe the

mediators of acute inflammation(PA

4.2)(VI-GS)

SGD-Pharmacology (A+B)ADVERSE DRUG

INTERACTION PH 1.7 /Pathology C+D PA 3.1-

Describe the pathogenesis and pathology of

amyloidosis

PA 3.2-Identify and describe amyloidosis in a

pathology specimen

P-Microbiology Introduction - Viruses - 2 -


MI1.1(A+B)/FMT(C+D)GENERAL TOXICOLOGY -

3

FM 14.2,14.3


26

26/3/2021 FridayL-Microbiology MI1.1 Introduction -

Parasites - 1 - Classification

SGD-Pharmacology(C+D)DRUG INTERACTIONS

PH 1.8/Pathology A+B Tutorial/ Formative

assessment- Cell Injury

P-Microbiology Introduction - Bacteria - 1 -

Laboratory Diagnosis (Isolation &

Identification)

MI1.1(C+D)/FMT(A+B)GENERAL TOXICOLOGY -

3

FM 14.2,14.3


SDL-MicrobiologyMI 1.6 Drug Resistance

(C+D) /PSM (A&B)

28 28/3/2021 Sunday

29/03/2021 Monday

29

30/3/2021 TuesdayPharmacology PHARMACOLOGY OF

SYMPATHETIC AMINES PH 1.13

Pathology-Define and describe chronic

inflammation including causes, types enumerate

types,

non-specific and granulomatous; and examples

of each(PA 4.3)

Pharmacology(A+B) PARENTRAL ROUTE OF

DRUG ADMINISTRATION PH 2.1/

Pathology(C+D)Erythrocyte Sedimentation

Rate(ESR) (PY2.11)

30

31/3/2021 WednesdayMicrobiology MI1.4 Sterilization &

Disinfection

Pharmacology THERAPEUTIC USES OF

SYMPATHOMIMETIC AGENTS PH 1.13

Pharmacology(C+D) PARENTRAL ROUTE OF


Pathology(A+B)Erythrocyte Sedimentation

Rate(ESR) (PY2.11)

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting


NA

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting


NA

Holiday-Dhuleti

Clinical Posting

Clinical Posting

31

01/04/2021 Thursday

Pathology-PA 5.1 - Define and describe

the process of repair and regeneration

including wound healing

and its types( VI-GS)

SGD-Pharmacology(A+B) DRUG INTERACTIONS

PH 1.8/Pathology C+D Tutorial/ Formative

assessment- Cell Injury

MicrobiologyIntroduction - Bacteria - 1 -

Laboratory Diagnosis (Isolation &

Identification) MI1.1(A+B)/FMT(C+D) LEGAL

PROCEDURE-1

FM 14.20,14.22


3202/04/2021 Friday

33

03/04/2021 Saturday L-Medicine L-Surgery L-Obs & gynec

SDL-Pharmacology(A+B)/

Pathology(C+D)Enumerate And Describe

The Pathogenesis Of Disorders Caused

by air pollution Enumerate The Causes Of

OBESITY And Its Clinical Significance(PA

12.1,PA 12.3) PHASES OF CLINICAL TRIAL

AND NEW DRUG DEVELOPMENT PH 1.64

3404/04/2021 Sunday

35

05/04/2021 Monday

L-Pathology-PA 6.1 - Define and describe

edema, its types, pathogenesis and

clinical correlations.( VI-GM)

L-FMT LEGAL PROCEDURE-1

FM 1.3-1.7 SGD-PSM(CM6.4Measures of Central

tendency)Patho-General Medicine

36

06/04/2021 TuesdayL-Pharmacology ALPHA RECEPTOR

BLOCKERS PH 1.13

L-Pathology-PA 6.3 - Define and describe shock,

its pathogenesis and its stages.( VI-GS)

P-Pharmacology(A+B) TOPICAL ROUTE OF


Pathology(C+D)Total Leucocyte count (PY

2.11)


37

07/04/2021 WednesdayL-Microbiology MI1.7 Immunology -

Introduction - Immunity

L-Pharmacology BETA RECEPTOR BLOCKERS PH

1.13

P-Pharmacology(C+D) TOPICAL ROUTE OF


Pathology(A+B)otal Leucocyte count (PY 2.11)

38

08/04/2021 Thursday

L-Pathology-PA 6.4b - Describe the

etiopathogenesis and consequences of

thrombosis

SGD-Pharmacology (A+B)THERAPEUTIC USES OF

SYMPATHOMIMETIC AGENTS PH 1.13/Pathology

C+D Tutorial/ Formative assessment -

Inflammation (PA 4)

P-MicrobiologyIntroduction - Bacteria - 2 -


(ABST)MI1.1/1.6(A+B)/FMT(C+D)LEGAL

PROCEDURE-1

FM 14.20,14.22

39

09/04/2021 FridayL-Microbiology MI1.7 Structure &

Function of immune system

SGD-Pharmacology (C+D)THERAPEUTIC USES OF

SYMPATHOMIMETIC AGENTS PH 1.13/Pathology

A+B Tutorial/ Formative assessment -

Inflammation (PA 4)



(ABST)MI1.1/1.6(C+D)/FMT(A+B) LEGAL

PROCEDURE-1

FM 14.20,14.22

40


SDL-Pharmacology(C+D)/

Pathology(A+B)Enumerate And Describe

The Pathogenesis Of Disorders Caused

by air pollution Enumerate The Causes Of

OBESITY And Its Clinical Significance(PA

12.1,PA 12.3) PHASES OF CLINICAL TRIAL

AND NEW DRUG DEVELOPMENT PH 1.64

41 11/04/2021 Sunday

42

12/04/2021 Monday


embolism and its causes and common

types.

L-PSM(CM5.6,Enumerate and discuss the

National Nutrition Policy, )

SGD-PSM(CM6.4Measures of dispersion,

confidence interval. Normal curve)

4313/04/2021 Tuesday

4414/04/2021 Wednesday

45

15/04/2021 ThursdayL-Pathology-PA 7.1a - Define and classify

neoplasia, biologic behavior and spread.

SGD-Pharmacology (A+B)CHOLINOMIMETIC

AGENTS 1 PH 1.14/Pathology C+D Tutorial /

formative assessment- Healing and repair (PA 5)



(Automation)MI1.1(A+B)/FMT(C+D) SDL-

LEGAL PROCEDURE

46

16/04/2021 FridayL-Microbiology MI1.7 Antigen - General

Properties

SGD-Pharmacology (C+D)CHOLINOMIMETIC

AGENTS 1 PH 1.14/Pathology A+B Tutorial /

formative assessment- Healing and repair(PA 5)



(Automation)MI1.1(C+D)/FMT(A+B) SDL-

LEGAL PROCEDURE

47

17/04/2021 Saturday L-Medicine L-Surgery L-Obs & gynecSDL-Microbiology MI 1.9

Immunoprophylaxis (A+B)/PSM (C+D)

48 18/04/2021 Sunday

Clinical Posting

Holiday-Good Friday


NA

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting


NA

Clinical Posting

Holiday-chetichand

Holiday-Dr.babasaheb Ambedkar Jyanti

Clinical Posting

Clinical Posting


49

19/04/2021 MondayL-Pathology-PA 7.1a - Define and classify

neoplasia, biologic behavior and spread.

L-FMT LEGAL PROCEDURE-1

FM 1.3-1.7

SGD-PSM(CM7.4,Morbidity +mortality

indicators)

50

20/04/2021 TuesdayL-Pharmacology SYSTEM ENDING TEST

OF GENERAL PHARMACOLOGY

L-Pathology-PA 7.2 - Describe the molecular

basis of cancer.

P-Pharmacology(A+B)PREPARATION OF ORAL

REHYDRATION SALT PH 2.2/

Pathology(C+D)Peripheral blood Smear

preparation and differential leucocyte

count(PA 13.5,PA 15.3,

PY 2.11)


52

22/04/2021 ThursdayL-Pathology-PA 7.2 - Describe the

molecular basis of cancer.

SGD-Pharmacology (A+B)CHOLINOMIMETIC

AGENTS 2 PH 1.14/Pathology C+D Tutorial/

Formative assessment – Hemodynamic

Disorders (PA 6)

P-Microbiology Introduction - Fungi - 2 -

Laboratory Diagnosis MI1.1(A+B)/FMT(C+D)

AGRICULTURE POISONS-1

FM 9.5

53

23/04/2021 FridayL-Microbiology MI1.7 Antibody - Types /

Structure & Functions

SGD-Pharmacology(C+D)CHOLINOMIMETIC

AGENTS 2 PH 1.14/Pathology A+B Tutorial/

Formative assessment – Hemodynamic

Disorders (PA 6)

P-Microbiology Introduction - Fungi - 2 -

Laboratory Diagnosis MI1.1(C+D)/FMT(A+B)


FM 9.5

54

24/04/2021 Saturday L-Medicine L-Surgery L-Obs & gynecSDL-Microbiology MI 1.9

Immunoprophylaxis (C+D) /PSM (A&B)

55 25/04/2021 Sunday

56

26/04/2021 Monday

L-Pathology-PA 7.3 - Enumerate

carcinogens and describe the process of

carcinogenesis

L-PSM(CM5.6,Important national nutritional

Programs Excluding ICDS)SGD-PSM(CM7.5,Descriptive studies)

57

27/04/2021 Tuesday

L-Pharmacology ANTICHOLINERGIC

AGENTS: ATROPINE AND HYOSCINE PH

1.14

L-Pathology-PA 7.3 - Enumerate carcinogens and

describe the process of carcinogenesis

P-Pharmacology(A+B)DOSAGE CALCULATION

PH 2.4/ Pathology(C+D)Peripheral blood

smear – microcytic, macrocytic & haemolytic

anemia (PA 13.5, PA 14.3PA 15.3, PA 16.6)

58

28/04/2021 Wednesday L-Microbiology MI1.7 Ag-Ab Reaction

L-Pharmacology ANTICHOLINERGIC AGENTS:

SEMISYNTHETIC AND SYNTHETIC ATROPINE

SUBSTITUTES PH 1.14

P-Pharmacology(C+D)PREPARATION OF ORAL

REHYDRATION SALT PH 2.2 /

Pathology(A+B)Peripheral blood Smear

preparation and differential leucocyte

count(PA 13.5,PA 15.3,

PY 2.11)

59

29/04/2021 Thursday

L-Pathology-PA 9.3 - Describe the HLA

system and the immune principles

involvedin transplant and

mechanism of transplant rejection. (HI-

MI)

SGD-Pharmacology (A+B)PHARMACOTHERAPY

OF ORGANOPHOSPHROUS POISONING PH

1.14/Pathology C+D PA7.4 Describe the effects

of tumor on the host including paraneoplastic

syndrome

PA7.5 Describe immunology and the immune

response to cancer

P-Microbiology Introduction - Parasites - 1 -

Laboratory Diagnosis MI1.1(A+B)/FMT(C+D)


FM 9.5

Patho-Micro

60

30/04/2021 FridayL-Microbiology MI1.7 Complement

System

SGD-Pharmacology(C+D)PHARMACOTHERAPY

OF ORGANOPHOSPHROUS POISONING PH

1.14/Pathology A+B PA7.4 Describe the effects

of tumor on the host including paraneoplastic

syndrome

PA7.5 Describe immunology and the immune

response to cancer

P-Microbiology Introduction - Parasites - 1 -

Laboratory Diagnosis MI1.1(C+D)/FMT(A+B)


FM 9.5

6101/05/2021 Saturday L-Medicine L-Surgery L-Obs & gynec SDL-Pharmacology(A+B)/Pathology(C+D)

62 02/05/2021 Sunday

63

03/05/2021 Monday

L-Pathology PA 9.4 - Define

autoimmunity. Enumerate autoimmune

disorders.PA9.7 Define and describe the

pathogenesis of other common

autoimmune diseases(VI- GM)

L-FMT IDENTIFICATION-1

FM 3.1-3.2(anatomy) SGD-PSM(CM7.5,Case control)

Patho-General Medicine

FMT-Anatomy

64

04/05/2021 Tuesday L-Pharmacology Revision

L-Pathology PA 9.5 - Define and describe the

pathogenesis of Systemic Lupus

Erythematosus.(VI- GM

P-Pharmacology(A+B)/Pathology(C+D)

Clinical Posting

Clinical Posting

HOLIDAY- RAMNAVMI

Clinical Posting

Clinical Posting


NA

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting


NA

Clinical Posting

Clinical Posting

65

05/05/2021 WednesdayL-Microbiology MI1.8 Cell Mediated

Imune ResponseL-Pharmacology Revision P-Pharmacology(C+D)/Pathology(A+B)

66

06/05/2021 Thursday

L-Pathology PA 9.6 - Define and describe

the pathogenesis and pathology of HIV

and AIDS.(VI- GM HI-MI)

SGD-Pharmacology/Pathology

P-Microbiology Sterilization & Disinfection

MI1.5(A+B)/FMT(C+D) CORROSIVES-1

FM 9.1

Patho-Micro Patho-General Medicine

67

07/05/2021 FridayL-Microbiology MI1.8 Humoral Immune

ResponseSGD-Pharmacology/Pathology

P-Microbiology Sterilization & Disinfection

MI1.5(C+D)/FMT(A+B) CORROSIVES-1

FM 9.1

68

08/05/2021 Saturday L-Medicine L-Surgery L-Obs & gynec SDL-Pharmacology(C+D)/Pathology(A+B)

69 09/05/2021 Sunday

70

10/05/2021 Monday

L-Pathology PA 10.3 - Define and

describe the pathogenesis and pathology

of leprosy.(VI- GM HI - MI)

L-PSM(CM5.6,Integrated Child Development

Services Scheme (ICDS) SGD-PSM(CM7.5,Cohort) Patho-Micro Patho-General Medicine

71

11/05/2021 Tuesday L-Pharmacology Revision

L-Pathology PA 11.1 Describe the pathogenesis

and features of common cytogenetic

abnormalities and mutations in childhood (VI-

pediatrics)

P-Pharmacology(A+B)/Pathology(C+D)

7212/05/2021 Wednesday L-Microbiology MI1.10 Hypersensitivity L-Pharmacology Revision P-Pharmacology(C+D)/Pathology(A+B)

73

13/05/2021 Thursday

L-Pathology PA 11.2 Describe the

pathogenesis and pathology of tumor

and tumor like conditions in infancy and

childhood(VI- pediatrics)

SGD-Pharmacology/Pathology

P-Microbiology Collection & Transport of

specimen MI8.10(A+B)/FMT(C+D)

CORROSIVES-2

FM 9.1

Patho-Pediatrics

7414/05/2021 Friday


SDL-Microbiology MI 1.11 Clinical

Transplantation(A+B)/PSM (C+D)

76 16/05/2021 Sunday

77

17/05/2021 Monday

L-Pathology-PA 9.4 - Define

autoimmunity. Enumerate autoimmune

disorders.(VI- GM)


FM 3.1-3.2(anatomy) SGD-PSM(CM7.5,Experimental)


FMT-Anatomy

78

18/05/2021 TuesdayL-PharmacologyPHARMACOTHERAPY OF

GLAUCOMA PH 1.58

L-Pathology-PA 9.5 - Define and describe the

pathogenesis of Systemic Lupus

Erythematosus.(VI- GM)

P-Pharmacology(A+B)SETTING OF

INTRAVENOUS INFUSION SET PH 2.3 /

Pathology(C+D)Hematopoiesis and bone

marrow examination(PA 13.1, PA 17.2)


79

19/05/2021 Wednesday L-Microbiology MI1.10 AutoimmunityL-PharmacologySYSTEM ENDING TEST OF

AUTONOMIC PHARMACOLOGY

P-Pharmacology(C+D)DOSAGE CALCULATION

PH 2.4/ Pathology(A+B)Peripheral blood

smear – microcytic, macrocytic & haemolytic

anemia (PA 13.5, PA 14.3PA 15.3, PA 16.6)

80

20/05/2021 Thursday


the pathogenesis and pathology of HIV

and AIDS.(VI- GM HI-MI)

SGD-Pharmacology (A+B) ESSENTIAL

DRUGS/Pathology C+D Tutorial/ Formative

assessment-Neoplasia (PA 7)

P-Microbiology Handling of Specimens -

Respect MI8.11 (A+B)/FMT(C+D)

IDENTIFICATION FM 3.1


81

21/05/2021 FridayL-Microbiology MI1.10

Immunodeficiency diseases

SGD-Pharmacology(C+D) ESSENTIAL

DRUGS/Pathology A+B Tutorial/ Formative

assessment-Neoplasia (PA 7)

P-MicrobiologyCollection & Transport of

specimen MI8.10(C+D)/FMT(A+B)



SDL-Microbiology MI 1.11 Clinical

Transplantation(C+D) /PSM (A&B)

83 23/05/2021 Sunday

84

24/05/2021 Monday


the pathogenesis of other common

autoimmune diseases.(VI- GM)

L-PSM(CM7.1+7.2,Define Epidemiology and

describe and enumerate the principles, concepts

and uses)

SGD-PSM(CM7.6,Screening) Patho-General Medicine

Clinical Posting

Clinical Posting

Clinical Posting


NA

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Holiday-Bhagwan Shree Parshuram Jyanti


NA

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting


NA

Clinical Posting

85

25/05/2021 Tuesday L-Pharmacology DIURETICS PH 1.24

L-Pathology-PA 10.3 - Define and describe the

pathogenesis and pathology of leprosy.(VI- GM

HI - MI)

P-Pharmacology(A+B)INTERPRETION OF

GRAPHS 4.2/ Pathology(C+D)Urine

examination(PA 23.1)


86

26/05/2021 WednesdayL-Microbiology MI1.11 Transplantation

Immunology

L-Pharmacology DRUGS ACTING ON RENIN

ANGIOTENSIN ALDOSTERONE SYSEM 1 PH 1.26

P-Pharmacology(C+D)SETTING OF

INTRAVENOUS INFUSION SET PH 2.3/

Pathology(A+B)Hematopoiesis and bone

marrow examination(PA 13.1, PA 17.2)

87

27/05/2021 ThursdayL-Pathology-PA-13.3 - Define and classify

anemia VI-GM

SGD-Pharmacology (A+B)TARGET SITES OF

ANTIHYPERTENSIVE AGENTS/Pathology (C+D)PA

9.1Describe the principles and mechanisms

involved in immunity

PA9.2 Describe the mechanism of

hypersensitivity reactions

P-Microbiology Gram staining

MI1.2(A+B)/FMT(C+D) IDENTIFICATION FM

3.2


88

28/05/2021 FridayL-Microbiology MI1.11 Tumor

immunology & Immunohematology

SGD-Pharmacology (C+D)TARGET SITES OF

ANTIHYPERTENSIVE AGENTS/Pathology A+B PA

9.1Describe the principles and mechanisms

involved in immunity

PA9.2 Describe the mechanism of

hypersensitivity reactions

P-Microbiology Handling of Specimens -

Respect MI8.11 (C+D)/FMT(A+B)


89


SDL-Pharmacology(A+B)/

Pathology(C+D)Enumarate And Discribe

Pathogenesis Of Disorders Caused By

Tobacco And Alcohol(PA

12.1)PHARMACOTHERAPY OF SHOCK PH

1.27

9030/05/2021 Sunday

91

31/05/2021 Monday

L-Pathology-PA-13.4 - Enumerate and

describe the investigation of anemia VI-

GM


FM 3.1-3.2(anatomy)

SGD-PSM(CM9.2,Define, calculate and

interpret demographic indices including birth

rate, death rate, fertility rates)


92

01/06/2021 TuesdayL-Pharmacology PHARMACOLOGY

CALCIUM CHANNEL BLOCKERS PH 1.27

L-Pathology-PA14.1 Describe iron metabolism

PA14.2 Describe the etiology, investigations and

differential diagnosis of microcytic hypochromic

anemia

P-Pharmacology(A+B)LOGBOOK ASSESSMENT

/ Pathology(C+D)Immuno haematology-blood

banking(PA 22.2, PA16.7,PA 22.4)

93

02/06/2021 Wednesday L-Microbiology MI2.1 Rheumatic Fever L-Pharmacology VASODILATORS PH 1.27

P-Pharmacology(C+D)INTERPRETION OF

GRAPHS 4.2/ Pathology(A+B)Urine

examination(PA 23.1)

94

03/06/2021 Thursday

L-Pathology-PA 15.1 - Describe the

metabolism of Vitamin B12 and the

etiology and pathogenesis of B12

Deficiency(VI-GM BIO)

PA 15.2 - Describe laboratory

investigations of macrocytic anemia(VI-

GM )

PA 15.4 - Enumerate the differences and

describe the distinguishing features of

megaloblastic

and non-megaloblastic macrocytic

anemia(VI-GM)

SGD-Pharmacology (A+B)CENTRALLY ACTING

ANTIHYPERTENSIVE AGENTS PH 1.27/Pathology

C+D Case based discussion of 1.Sickle cell

anemia; 2. Thalassemia; 3. Hereditary

spherocytosis; 4. Autoimmune hemolytic anemia

(PA 16.4)

P-Microbiology ZN staining MI1.3

(A+B)/FMT(C+D) FORENSIC PATHOLGOY

2.11,2.12,2.13,2.14


Biochemistry

95

04/06/2021 FridayL-Microbiology MI2.2 Bacterial

Endocarditis

SGD-Pharmacology(C+D)CENTRALLY ACTING

ANTIHYPERTENSIVE AGENTS PH 1.27/Pathology

A+B Case based discussion of 1.Sickle cell

anemia; 2. Thalassemia; 3. Hereditary

spherocytosis; 4. Autoimmune hemolytic

anemia(PA 16.4)

P-Microbiology Gram staining

MI1.2(C+D)/FMT(A+B) FORENSIC PATHOLGOY

2.11,2.12,2.13,2.14

96


SDL-

Pharmacology(C+D)PHARMACOTHERAPY

OF SHOCK PH 1.27/

Pathology(A+B)Enumarate And Discribe

Pathogenesis Of Disorders Caused By

Tobacco And Alcohol(PA 12.1)

97 06/06/2021 Sunday

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting


NA

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting


NA

98

07/06/2021 Monday

L-Pathology-PA-16.1 - Define and classify

hemolytic anemia(VI-GM BIO)

PA 16.2 - Describe the pathogenesis and

clinical features and hematologic indices

of hemolytic anemia(VI-GM BIO)

PA 16.5 - Describe the peripheral blood

picture in different hemolytic

Anaemias(VI-GM )

L-PSM(CM7.1+7.2,Enumerate, describe and

discuss the modes of transmission and measures

for prevention and control of communicable and

non- communicable diseases)

SGD-PSM(CM7.9,Describe and demonstrate

the application of computers in

epidemiology/ statistics)


Biochemistry

99

08/06/2021 TuesdayL-PharmacologySYMPATHOLYTICS IN

HYPERTENSION PH 1,27

L-Pathology-PA-16.3 - Describe the

pathogenesis, features, hematologic indices and

peripheral blood picture

of sickle cell anemia and thalassemia(VI-GM

BIO)

P-Pharmacology(A+B)DEMONSTRATION OF

EFFECTS OF DRUG ON BLOOD PRESSURE

USING CAL PH 4.2/ Pathology(C+D)STUDY OF

CELLS, TISSUES AND FIXATIVES


Biochemistry

100

09/06/2021 Wednesday L-Microbiology MI2.5 Kala azarL-PharmacologyPHARMACOTHERAPY OF

HYPERTENSION 1 PH 1.27

P-Pharmacology(C+D)LOGBOOK

ASSESSMENT/ Pathology(A+B)mmuno

haematology-blood banking(PA 22.2,

PA16.7,PA 22.4)

101

10/06/2021 Thursday

L-Pathology-PA-16.4a - Describe the

etiology pathogenesis, hematologic

indices and peripheral blood picture of

Acquired hemolytic anemia(VI-GM BIO)

SGD-Pharmacology (A+B)SELECTION OF

ANTIHYPERTENSIVE AGENTS IN DIFFERENT

CONDITIONS PH 1.27./Pathology C+D PA18.1

Enumerate and describe the causes of

leucocytosis leucopenia lymphocytosis and

leukemoid reactions

P-Microbiology Hospital Waste Management

(CSSD/BMW) MI1.5(A+B)/FMT(C+D)

FORENSIC PATHOLGOY 2.11,2.12,2.13,2.14


Biochemistry

102

11/06/2021 FridayL-Microbiology MI2.5,IM4.6,IM4.15

Malaria

SGD-Pharmacology(C+D)SELECTION OF

ANTIHYPERTENSIVE AGENTS IN DIFFERENT

CONDITIONS PH 1.27./Pathology A+B PA18.1

Enumerate and describe the causes of

leucocytosis leucopenia lymphocytosis and

leukemoid reactions

P-Microbiology ZN staining MI1.3

(C+D)/FMT(A+B) FORENSIC PATHOLGOY

2.11,2.12,2.13,2.14

103

12/06/2021 Saturday L-Medicine L-Surgery L-Obs & gynecSDL-Microbiology Blood Tranfusion -

Infection (A+B)/PSM (C+D)

10413/06/2021 Sunday

105

14/06/2021 Monday

L-Pathology-PA-17.1 - Enumerate the

etiology, pathogenesis and findings in

aplastic anemia(VI-GM ) PA-17.2 -

Enumerate the indications and describe

the findings in bone marrow aspiration

and

biopsy(VI-GM

L-FMT General Toxicology FM 8.1,8.2,8.3, SGD-PSM Patho-General Medicine

106 15/06/2021 Tuesday

107 16/06/2021 Wednesday

108 17/06/2021 Thursday

109 18/06/2021 Friday

110 19/06/2021 Saturday

111 20/06/2021 Sunday

112 21/06/2021 Monday

113 22/06/2021 Tuesday

114 23/06/2021 Wednesday

115 24/06/2021 Thursday

116 25/06/2021 Friday

117 26/06/2021 Saturday

118 27/06/2021 Sunday

119 28/06/2021 Monday

120 29/06/2021 Tuesday

121 30/06/2021 Wednesday

122

01/07/2021 Thursday

L-Pharmacology PH 1.42, 1.43

Antimicrobials

General considerations SGD-Pharmacology(C+D)/Pathology A+B P-Microbiology(C+D)/FMT(A+B)

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

CLINICAL POSTING -PSM -TERM ENDING EXAM


Clinical Posting

Clinical Posting

FIRST INTERNAL EXAMINATION

123

02/07/2021 Friday L-Microbiology HIV - 1 General (MI2.7)

L-PSM(CM:7.1,7.2,Enumerate describe and

disscuss the modes of transmission and mesures

fro prevention and comtrol of communicable

and non-communicable diseases)

AETCOM Pharmacology Mod 2.1 & 2.2

12403/07/2021 Saturday L-Medicine SDL-Pharmacology(A+B)/ Pathology(C+D)

125 04/07/2021 Sunday

126

05/07/2021 MondayL-PharmacologyPH 1.48 Sulphonamides,

cotrimoxazole and quinolones

L-Pathology PA 29.2 Describe the pathogenesis,

pathology, presenting and distinguishing

features, diagnostic tests, progression and

spread of carcinoma of the penis VI-GS PA29.5

Describe the etiology, pathogenesis, pathology

and progression

of prostatitis VI-GS

P-Pharmacology(A+B)/ Pathology(C+D)- Patho-General Surgery

127

06/07/2021 Tuesday


epidemiology, pathogenesis, etiology,

pathology screening, diagnosis and

progression of carcinoma of the CERVIX

VI- OBGY

L-Pharmacology PH 1.48 Beta lactam

antibiotics-1P-Pharmacology(C+D)/ Pathology(A+B)- Pathology- Obs & gyne

12807/07/2021 Wednesday

L-Microbiology HIV - Laboratroy

Diagnosis (MI2.7)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

12908/07/2021 Thursday

L-PharmacologyPH 1.48 Beta lactam

antibiotics-2SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B)

130

09/07/2021 FridayL-Microbiology Diarrhoea - Bacterial - 1 -

Cholera (MI3.1)

L-FMT DEATH AND ITS CAUSES-1

FM 2.1 , 2.7 ([PATHO, AETCOM,PSYCHIATRY)AETCOM Pharmacology Mod 2.1 & 2.2

13110/07/2021 Saturday L-Surgery

SDL-Pharmacology(C+D) /

Pathology(A+B)

132 11/07/2021 Sunday

133

12/07/2021 MondayL-Pharmacology PH 1.48 Tetracyclines&

Chloramphenichol

L-Pathology PA22.6 Describe transfusion

reactions and enumerate the steps in the

investigation of a transfusion reaction VI-GM

P-Pharmacology(A+B)/ Pathology(C+D)- Patho-General Medicine

134

13/07/2021 Tuesday

L-Pathology PA24.2 Describe the

etiology, pathogenesis, pathology,

microbiology,

clinical and microscopic features of

peptic ulcer disease PA24.3 Describe and

identify the microscopic features of

peptic ulcer VI-GM

L-Pharmacology PH 1.48 Aminoglycosides P-Pharmacology(C+D)/ Pathology(A+B)- Patho-General Medicine

13514/07/2021 Wednesday

L-Microbiology Diarrhoae - Bacteria - 2 -

E. coli(MI3.1)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

13615/07/2021 Thursday L-Pharmacology PH 1.48 Macrolides SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B)

137

16/07/2021 FridayL-Microbiology Diarrhoea / Dysentery -

Shigella & Campylobacter(MI3.1)

L-PSM(CM7.8,Describe the principles of

association, causation and biases in

epidemiological studies)

AETCOM PSM Mod 2.3 & 2.4

13817/07/2021 Saturday L-Obs & Gynec SDL-Microbiology (C+D) /PSM (A&B)

139 18/07/2021 Sunday

140

19/07/2021 Monday

L-Pharmacology PH 1.44 Antitubercular

drugs-1 (VI - Respiratory Medicine) (HI -

Microbiology)

L-Pathology PA24.4 Describe and etiology and

pathogenesis and pathologic

features of carcinoma of the stomach VI- GS

P-Pharmacology(A+B)/ Pathology(C+D)- Patho-Micro Patho-General Surgery

141

20/07/2021 Tuesday

L-Pathology PA24.6 Describe and

etiology and pathogenesis and pathologic

and

distinguishing features of Inflammatory

bowel disease VI-GS

L-Pharmacology PH 1.44 Antitubercular drugs-2

(VI - Respiratory Medicine) (HI - Microbiology)P-Pharmacology(C+D)/ Pathology(A+B)- Pharma-Micro


Pharma-Resp medicine

Clinical Posting

AETCOM Pharmacology Mod. 2.1 & 2.2 SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM Pharmacology Mod. 2.1 & 2.2 SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM PSM Mod 2.3 & 2.4 SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

14221/07/2021 Wednesday

143

22/07/2021 Thursday

L-Pharmacology PH 1.46 Anti-leprotic

drugs (VI-Dermatology) (HI -

Microbiology)

SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B) Pharma-Micro Phrama-Dermatology

144

23/07/2021 Friday L-Microbiology Enteric Fever(MI3.3)L-FMT DEATH AND ITS CAUSES-2

FM 2.1 , 2.7 ([ATHO, AETCOM,PSYCHIATRY)AETCOM PSM 2.3 & 2.4

14524/07/2021 Saturday L-Medicine SDL-Microbiology (A&B) /PSM (C+D)

146 25/07/2021 Sunday

147

26/07/2021 Monday L-Pharmacology PH 1.48, 1.55 Antivirals

L-Pathology PA24.7 Describe the etiology,

pathogenesis, pathology and

distinguishing features of carcinoma of the colon

VI-GS

P-Pharmacology(A+B)/ Pathology(C+D)- Patho-General Surgery

148

27/07/2021 Tuesday

L-Pathology PA25.3 Describe the etiology

and pathogenesis of viral and toxic

hepatitis: distinguish the causes of

hepatitis based on the

clinical and laboratory features. Describe

the pathology,

complications and consequences of

hepatitis VI-GM

L-Pharmacology PH 1.47 Antimalarials-1 (VI -

Medicine) (HI - Microbiology) P-Pharmacology(C+D)/ Pathology(A+B)- Pharma-Micro Pharma- General Medicine

14928/07/2021 Wednesday

L-Microbiology Intestinal - Parasitic -1 -

Amoebic dysentery(MI3.6)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

15029/07/2021 Thursday

L-Pharmacology PH 1.47 Antimalarials-2SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B)

151

30/07/2021 FridayL-Microbiology Intestinal - Parasitic - 2 -

Giardiasis & Misc. Protozoa(MI3.6)

L- PSM (CM7.3,9.7Enumerate, describe and

discuss the sources of epidemiological

data,Enumerate the sources of vital statistics

including census, SRS, NFHS, NSSO etc)

AETCOM FMT Mod 2.5 & 2.6

15231/07/2021 Saturday L-Surgery


Pathology(A+B)

153 01/08/2021 Sunday

154

02/08/2021 MondayL-Pharmacology PH 1.25 Antiplelet

agents (VI - Physiology, Medicine)


pathophysiology, pathology and progression of

alcoholic liver disease including cirrhosis VI-

GM,GS

P-Pharmacology(A+B)/ Pathology(C+D)-

Pharma- General

Medicine, Physiology

Patho-GS,GM

155

03/08/2021 Tuesday


etiology, pathogenesis and complications

of portal

hypertension VI-GM,GS

L-Pharmacology PH 1.25 Coagulants and

Anticoagulants (VI - Physiology, Medicine)P-Pharmacology(C+D)/ Pathology(A+B)-

Pharma- Physiology ,

General Medicine, Patho-

General Surgery, General

Medicine

156

04/08/2021 WednesdayL-Microbiology Intestinal - Parasitic - 3 -

Taeniasis (MI3.6)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

157

05/08/2021 Thursday

L-Pharmacology Fibrinolytic and

antifibrinolytics (VI - Physiology,

Medicine)

SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B)Pharma- Physiology ,

General Medicine

15806/08/2021 Friday

L-Microbiology Intestinal - Parasitic - 4 -

Hydatid Disease (MI3.6)

L-FMT PM CHANGES-1

FM 2.8, 2.10 AETCOM FMT Mod 2.5 & 2.6

15907/08/2021 Saturday L-Obs & Gynec SDL-Pharmacology(A+B)/ Pathology(C+D)

160 08/08/2021 Sunday

161

09/08/2021 MondayL-PharmacologyPH 1.47 1.55 Anti-

amoebic agents

L-Pathology PA26.1 Define and describe the

etiology, types, pathogenesis, stages,

morphology and complications of pneumonia VI-

GM HI-MICRO

P-Pharmacology(A+B)/ Pathology(C+D)- Patho-Micro Patho-General Medicine

162

10/08/2021 Tuesday


etiology, gross and microscopic

appearance and

complications of lung abscess VI-GM, HI-

MICRO

L-Pharmacology PH 1.47 Antihelminthics P-Pharmacology(C+D)/ Pathology(A+B)- Patho-Micro Patho-General Medicine

HOLIDAY- BAKARA ID

Clinical Posting

Clinical Posting

AETCOM PSM 2.3 & 2.4 SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM FMT Mod 2.5 & 2.6 SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM FMT Mod 2.5 & 2.6 SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

16311/08/2021 Wednesday

L-Microbiology Intestinal - Parasites -

Trematodes (FH / FB / CS)(MI3.6)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

16412/08/2021 Thursday

L-Pharmacology PH 1.49 Anticancer

drugsSGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B)

165

13/08/2021 FridayL-Microbiology Intestinal - Parasites -

Nematodes (EV / TT) (MI3.6)

L-PSM( CM-7.7 : Describe and demonstrate the

steps in the Investigation of an epidemic of

communicable disease and describe the

principles of control measures

AETCOM FMT Mod 2.5 & 2.6 Medicine/microbiology

16614/08/2021 Saturday L-Medicine SDL-Microbiology (C+D) /PSM (A&B)

167 15/08/2021 Sunday

16816/08/2021 Monday HOLIDAY- PARASI NUTAN VARSH

169

17/08/2021 Tuesday

L-Pathology PA26.3 Define and describe

the etiology, types, pathogenesis, stages,

morphology and complications and

evaluation of Obstructive

airway disease (OAD) and bronchiectasis

VI-PHYSIO, GM HI-MICRO

L-Pharmacology PH 1.34 Drugs used in acid

peptic disorders (VI - Medicine) P-Pharmacology(C+D)/ Pathology(A+B)- Patho-Micro

Patho-Physio,General

Medicine

Pharma- General Medicine

170

18/08/2021 WednesdayL-Microbiology Intestinal - Parasites -

Nematodes (EV / TT) (MI3.6)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(C+D)/Pharmacology(A+B)

17119/08/2021 Thursday

17220/08/2021 Friday

L-Microbiology Intestinal - Virus -

Rotavirus(MI3.6)

L-FMT PM CHANGES-2

FM 2.8, 2.10 AETCOM Microbiology Mod 2.7

17321/08/2021 Saturday L-Surgery SDL-Microbiology (A&B) /PSM (C+D)

17422/08/2021 Sunday

175

23/08/2021 Monday

L-Pharmacology PH 1.34 Emetics and

antiemetics (VI - Medicine)

L-Pathology PA26.4 Define and describe the

etiology, types, pathogenesis, stages,

morphology microscopic appearance and

complications of

tuberculosis VI-GM HI-MICRO

P-Pharmacology(A+B)/ Pathology(C+D)- Patho-MicroPharma- General Medicine


176

24/08/2021 Tuesday


the etiology, types, exposure,

environmental influence, pathogenesis,

stages, morphology,

microscopic appearance and

complications of Occupational

lung disease VI-GM, CM

L-Pharmacology PH 1.34 Pharmacotherapy of

diarrhoea (VI - Medicine)P-Pharmacology(C+D)/ Pathology(A+B)-


Pharma-Medicine

17725/08/2021 Wednesday

L-Microbiology Viral Hepatitis - 1 - HBV

(MI3.7)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

178

26/08/2021 Thursday

L-Pharmacology PH 1.34

Pharmacotherapy of

Constipation (VI - Medicine)

SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B) Pharma- General Medicine

17927/08/2021 Friday L-Microbiology Part-End Examination

L-PSM (CM:7.2 , MANAGEMENT OF DIARRHOEA

(ADD/ cholera)AETCOM Pathology Mod 2.8 Paediatrics/medicine

18028/08/2021 Saturday L-Obs & Gynec


Pathology(A+B)

18129/08/2021 Sunday

182 30/08/2021 Monday

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM Microbiology Mod 2.7 SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

HOLIDAY-MOHARRAM

Clinical Posting

AETCOM Microbiology Mod 2.7 SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM Pathology Mod 2.8 SPORTS & EXTRACURRICULLAR ACTIVITIES

HOLIDAY-JANMASTHAMI

183

31/08/2021 Tuesday


the etiology, types, exposure, genetics


stages, morphology,

microscopic appearance,metastases and

complications of

tumors of the lung and pleura VI-GM

PA26.7 Define and describe the etiology,

types, exposure, genetics


morphology,

microscopic appearance and

complications of mesothelioma VI-

GM,CM

L-PharmacologyPH 1.32 Pharmacotherapy of

Bronchial Asthma I (VI- Respiratory Medicine)P-Pharmacology(C+D)/ Pathology(A+B)-


Pharma-Respitatory

Medicine

184

01/09/2021 WednesdayL-Microbiology Anaerobic Infections - 1 -

C. perfringens (MI4.1)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

185

02/09/2021 Thursday

L-PharmacologyPH 1.32

Pharmacotherapy of

Bronchial Asthma II (VI- Respiratory

Medicine)

SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B)Pharma-Respitatory

Medicine

18603/09/2021 Friday

L-Microbiology Anaerobic Infections - 2 -

Tetanus / Botulism (MI4.1)

L-FMT PM CHANGES-3

FM 2.8, 2.10 AETCOM Pathology Mod 2.8

18704/09/2021 Saturday L-Medicine SDL-Pharmacology(A+B)/ Pathology(C+D)

18805/09/2021 Sunday

189

06/09/2021 MondayL-Pharmacology Formative assessment of

chemotherapy

L-Pathology A27.1 Distinguish arteriosclerosis

from atherosclerosis. Describe the pathogenesis

and pathology of various causes and types of

arteriosclerosis VI-GM


190

07/09/2021 Tuesday


etiology, pathophysiology, pathology,

gross and

microscopic features, criteria and

complications of rheumatic

fever VI-GM HI-MICRO

L-Pharmacology PH 1.16 Non steroidal

antiinflammatory agents I P-Pharmacology(C+D)/ Pathology(A+B)- Patho-Micro Patho-General Medicine

191


L-Microbiology Skin and Soft Tissue

Infections - Staphylococcus &

Streptococcus (MI4.3)

SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

192

09/09/2021 Thursday

L-Pharmacology PH 1.16 Non steroidal

antiinflammatory agents II SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B)

19310/09/2021 Friday

194 11/09/2021 Saturday L-Surgery SDL-Microbiology (A&B) /PSM (C+D)

195 12/09/2021 Sunday

196

13/09/2021 Monday


Pharmacotherapy of

Migraine (VI -General Medicine)

L-Pathology PA 27.5 Describe the epidemiology,

risk factors, etiology,

pathophysiology, pathology, presentations, gross

and microscopic features, diagnostic tests and

complications of ischemic heart disease VI-GM

P-Pharmacology(A+B)/ Pathology(C+D)-Patho-General Medicine

Pharma-Medicine

197

14/09/2021 Tuesday

L-Pathology PA27.9 Classify and describe

the etiology, types, pathophysiology,

pathology, gross and microscopic

features, diagnosis and

complications of cardiomyopathies VI-

GM PHYSIOLOGY

L-Pharmacology Formative assessment of GIT P-Pharmacology(C+D)/ Pathology(A+B)-Patho-General Medicine,

Physiology

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM Pandemic mod 2.1 Microbiology SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

HOLIDAY-GANESH CHATURTHI


Clinical Posting

Clinical Posting

198


L-Microbiology Skin and Soft Tissue

Infections - Actinomycosis & Nocardia

(MI4.3)

SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

199

16/09/2021 Thursday

L-Pharmacology PH 1.37 Pharmacology

of anterior

pituitary hormonesSGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B)

20017/09/2021 Friday L-Microbiology Leprosy (MI4.3)

L-PSM(CM:Epidemiology of TYPHOID)AETCOM Pandemic mod 2.2 PSM

20118/09/2021 Saturday L-Obs & Gynec SDL-Microbiology(C+D)/PSM (A&B)

202 19/09/2021 Sunday

203

20/09/2021 Monday

L-Pharmacology PH 1.36 Antithyroid

agents (VI -Medicine)

L-Pathology PA28.1 Describe the normal

histology of the kidney PA28.5 Define and

classify glomerular diseases. Enumerate and

describe the etiology, pathogenesis,

mechanisms of glomerular

injury, pathology, distinguishing features and

clinical

manifestations of glomerulonephritis VI- GM,

PHYSIO


Patho-General Medicine,

Physiology

Pharma-Medicine

204

21/09/2021 Tuesday

L-Pathology PA28.5 Define and classify

glomerular diseases. Enumerate and


mechanisms of glomerular

injury, pathology, distinguishing features

and clinical

manifestations of glomerulonephritis VI-

GM,PHYSIO PA28.6 Define and describe

the etiology, pathogenesis, pathology,

laboratory, urinary findings, progression

and complications of

IgA nephropathy VI-GM PA28.7

Enumerate and describe the findings in

glomerular

manifestations of systemic disease VI-GM

L-Pharmacology PH 1.37 Pharmacology of

female sex

hormones - Estrogens (VI -Gynecology)P-Pharmacology(C+D)/ Pathology(A+B)-

Patho-General Medicine,

Physiology Pharma-

Gynec

20522/09/2021 Wednesday

L-Microbiology Superficial & Cutaneous

Mycoses (MI4.3)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

206

23/09/2021 Thursday

L-Pharmacology PH 1.37 Pharmacology

of female sex

hormones - Progesterones (VI -

Gynecology)

SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B) Pharma-Gynec

20724/09/2021 Friday

L-Microbiology Subcutaneous Mycoses

(MI4.3)

L-FMT PM CHANGES-4

FM 2.8, 2.10 AETCOM Pandemic mod 2.2 PSM

20825/09/2021 Saturday L-Medicine


Pathology(A+B)

209 26/09/2021 Sunday

210

27/09/2021 Monday

L-PharmacologyPH 1.37 Pharmacology of

androgens

and antiandrogens

L-Pathology PA28.8 Enumerate and classify

diseases affecting the tubular

interstitium VI-GM


211

28/09/2021 Tuesday


the etiology, pathogenesis, pathology,

laboratory, urinary findings, progression

and complications of

acute tubular necrosis VI-GM

L-PharmacologyPH 1.38 Pharmacology of

corticosteroids I (VI - Medicine) P-Pharmacology(C+D)/ Pathology(A+B)-Patho-General Medicine

Pharma-Medicine

212

29/09/2021 WednesdayL-Microbiology Viral Exanthem - Small

pox / Chickenpox / Measles (MI4.3)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

213

30/09/2021 Thursday

L-PH 1.38 Pharmacology of

corticosteroids II (Medicine) SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B) Pharma-Medicine

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM Pandemic mod 2.2 PSM SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting


Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

21401/10/2021 Friday L-Microbiology Part-End Examination

L-PSM(CM:Epidemiology of HEPATITIS)AETCOM Pandemic mod 2.3 Microbiology

21502/10/2021 Saturday

21603/10/2021 Sunday

217

04/10/2021 Monday


Pharmacotherapy of

infertility


pathogenesis, pathology, laboratory

findings, distinguishing features progression and

complications

of acute and chronic pyelonephritis and reflux

nephropathy VI-GS ANAT

P-Pharmacology(A+B)/ Pathology(C+D)-Patho-General Surgery,

Anatomy

218

05/10/2021 Tuesday

L-Pathology PA28.11 Define classify and

describe the etiology, pathogenesis

pathology, laboratory, urinary findings,

distinguishing features

progression and complications of

vascular disease of the

kidney VI-GM PA28.15 Describe the

etiology, genetics, pathogenesis,

pathology,

presenting features and progression of

thrombotic angiopathies VI-GM

L-Pharmacology PH 1.36 Pharmacology of

osteoporosis (VI - Medicine)P-Pharmacology(C+D)/ Pathology(A+B)-


Pharma-Medicine

21906/10/2021 Wednesday L-Microbiology URTI - (MI6.1) SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

220

07/10/2021 Thursday

L- PH 1.41 Uterine stimulants and

relaxants (VI - Gynecology) SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B) Pharma-Gynec

22108/10/2021 Friday L-Microbiology LRTI - (MI6.1)

L-FMT MECHANICAL INJURY-1

FM 3.3 (GEN.SURG.)AETCOM Pandemic mod 2.3 Microbiology

22209/10/2021 Saturday L-Surgery SDL-Pharmacology(A+B)/ Pathology(C+D)

223 10/10/2021 Sunday

224

11/10/2021 MondayL-PharmacologyFormative assessment of

endocrinology

L-Pathology PA28.14 Classify and describe the

etiology, genetics, pathogenesis,

pathology, presenting features, progression and

spread of renal

tumors VI-PAEDIA

P-Pharmacology(A+B)/ Pathology(C+D)- Patho-Pediatrics

225

12/10/2021 Tuesday

L-Pathology PA29.1 Classify testicular

tumors and describe the pathogenesis,


features, diagnostic

tests, progression and spread of

testicular tumors VI-GS

L-Pharmacology PH 1.17 Local anaesthetics (VI -

Anaesthesia)P-Pharmacology(C+D)/ Pathology(A+B)-


Pharma-Anaesthesia

22613/10/2021 Wednesday

L-Microbiology LRTI - Tuberculosis

(MI6.2/3)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

227

14/10/2021 Thursday

L-Pharmacology PH 1.18 General

anaesthetics (Anaesthesia) SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B) Pharma-Anaesthesia

22815/10/2021 Friday

L-Microbiology RTI - Viral - Influenza

(MI6.2/3)

L-PSM(CM:7.2,Epidemiology of POLIO) AETCOM Pandemic mod 2.4PSM &

Biochemistry

22916/10/2021 Saturday L-Obs & Gynec SDL-Microbiology (A&B) /PSM (C+D)

230 17/10/2021 Sunday

231 18/10/2021 Monday

232 19/10/2021 Tuesday

233 20/10/2021 Wednesday

234 21/10/2021 Thursday

235 22/10/2021 Friday

236 23/10/2021 Saturday

237 24/10/2021 Sunday

238 25/10/2021 Monday

239 26/10/2021 Tuesday

Clinical Posting

HOLIDAY- MAHATMA GANDHIJI JAYANTI

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM Pandemic mod 2.4PSM & Biochemistry SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM Pandemic mod 2.4PSM & Biochemistry SPORTS & EXTRACURRICULLAR ACTIVITIES

SECOND INTERNAL EXAMINATION

240 27/10/2021 Wednesday

241 28/10/2021 Thursday

242 29/10/2021 Friday

243 30/10/2021 Saturday

244 31/10/2021 Sunday

245

01/11/2021 Monday

L-PharmacologyPH 1.19 Anti epileptic

agents I (VI - Psychiatry, Physiology)

L-Pathology PA 29.2 Describe the pathogenesis,


features, diagnostic tests, progression and

spread of carcinoma of the penis VI-GS PA29.5

Describe the etiology, pathogenesis, pathology

and progression

of prostatitis VI-GS


Pharma-Psychiatrics,

Physiology Patho-

General Surgery

246

02/11/2021 Tuesday


pathogenesis, pathology, hormonal

dependency

presenting and distinguishing features,

urologic findings &

diagnostic tests of benign prostatic

hyperplasia VI-GS

L-PharmacologyPH 1.19 Anti epileptic agentsI I

(VI - Psychiatry, Physiology) P-Pharmacology(C+D)/ Pathology(A+B)-



Physiology

24703/11/2021 Wednesday

L-Microbiology RTI - Viral - Corona

(MI6.2/3)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

248 04/11/2021 Thursday

249 05/11/2021 Friday

250 06/11/2021 Saturday

251 07/11/2021 Sunday

252

08/11/2021 Monday

L-Pharmacology PH 1.19 Sedatives -

Hypnotics (VI - Psychiatry, Physiology)

L-Pathology PA29.4 Describe the pathogenesis,

pathology, hormonal dependency

presenting and distinguishing features,

diagnostic tests,

progression and spread of carcinoma of the

prostate VI-GS



Physiology Patho-

General Surgery

253

09/11/2021 Tuesday


epidemiology, pathogenesis, etiology,

pathology screening, diagnosis and

progression of carcinoma of the CERVIX

VI- OBGY

L-Pharmacology PH 1.19 - Antidepressant agents

(VI - Psychiatry, Physiology) P-Pharmacology(C+D)/ Pathology(A+B)-

Patho-Obs & Gynec


Physiology

254

10/11/2021 Wednesday L-Microbiology Part-End Examination SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

255

11/11/2021 Thursday

L-Pharmacology PH 1.19 -

Psychopharmacology (VI - Psychiatry,

Physiology)

SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B)


Physiology Patho-

General Surgery

256

12/11/2021 Friday

L-Microbiology Meningitis - Bacterial -

(N.G. / M.T / S.P / L.C / H.I / C.N.)

(MI5.1)


FM 3.3 (GEN.SURG.)

AETCOM Pandemic mod 2.5 Pharmac & Gen

Medicine

257 13/11/2021 Saturday L-Medicine L-Surgery

25814/11/2021 Sunday

25915/11/2021 Monday

260

16/11/2021 Tuesday


pathogenesis, etiology, pathology,

diagnosis and

progression and spread of carcinoma of

the endometrium VI-OBGY PA30.9

Describe the etiology, hormonal

dependence and morphology

of endometrial hyperplasia VI-OBGY

L-Pharmacology PH 1.19 - Opioid analgesics I(VI -

Psychiatry, Physiology) P-Pharmacology(C+D)/ Pathology(A+B)-

Patho-Obs & Gynec


Physiology

26117/11/2021 Wednesday

L-Microbiology Encaphalitis -

Microbiology (MI5.2)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

262

18/11/2021 Thursday

L-Pharmacology PH 1.19 - Opioid

analgesics II (VI - Psychiatry, Physiology) SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B)Pharma-Psychiatrics,

Physiology

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

AETCOM Pandemic mod 2.5 Pharmac & Gen Medicine SPORTS & EXTRACURRICULLAR ACTIVITIES

DUSHERA HOLIDAY

Clinical Posting

Clinical Posting

Clinical Posting

SECOND INTERNAL EXAMINATION

DIWALI VACATION

26319/11/2021 Friday

26420/11/2021 Saturday L-Obs & Gynec L-Medicine

265 21/11/2021 Sunday

266

22/11/2021 Monday


Pharmacotherapy of

Parkinsonism I



morphology, clinical course, spread and

complications of

ovarian tumors VI-OBGY


267

23/11/2021 Tuesday



morphology,

clinical course, spread and complications

of gestational

trophoblastic neoplasms VI-OBGY

L-Pharmacology PH 1.19 Pharmacotherapy of

Parkinsonism IIP-Pharmacology(C+D)/ Pathology(A+B)-

268

24/11/2021 WednesdayL-Microbiology CNS - Parasitic - PFA / TG

/ TCB / TS (MI5.2)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

269

25/11/2021 ThursdayL-Pharmacology Formative assessment

of CNSSGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B)

270

26/11/2021 FridayL-Microbiology CNS - Virus -

Poliomyelitis (MI5.2)

L-PSM(CM:7.2,Epidemiology of FOOD

POISONING) P-Microbiology (A+B)/Pathology(C+D)

271 27/11/2021 Saturday L-Surgery L-Obs & Gynec

27228/11/2021 Sunday

273

29/11/2021 MondayL-Pharmacology PH 1.56 Geriatric

Pharmacology


hormonal dependence, features and

morphology of endometriosis

PA30.8 Describe the etiology and morphologic

features of adenomyosis VI -OBGY


274

30/11/2021 Tuesday

L-Pathology PA 31.1 Classify and

describe the types, etiology,

pathogenesis, pathology and hormonal

dependency of benign breast disease VI-

ANAT, GS PA31.4 Enumerate and

describe the etiology, hormonal

dependency

and pathogenesis of gynecomastia VI-GM

PAEDIA

L-Pharmacology PH 1.56 Pediatric Pharmacology

(VI - Pediatric)P-Pharmacology(C+D)/ Pathology(A+B)-

27501/12/2021 Wednesday L-Microbiology STI(MI7.1/2) SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

27602/12/2021 Thursday

L-Pharmacology PH 1.4 Drugs in

PregnancySGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B)

27703/12/2021 Friday

L-Microbiology Gonorrhoea & NGU

(MI7.1/2)


FM 3.3 (GEN.SURG.)P-Microbiology(A+B)/Pharmacology(C+D)


27905/12/2021 Sunday

280

06/12/2021 Monday


Immunomodulators and

Immunosuppresants


epidemiology, pathogenesis,

classification, morphology, prognostic factors,

hormonal

dependency, staging and spread of carcinoma of

the breast VI- GS


281

07/12/2021 Tuesday

L-Pathology PA32.1 Enumerate, classify

and describe the etiology, pathogenesis,

pathology and iodine dependency of

thyroid swellings VI-ANAT PHYSIO GM GS

L-Pharmacology PH 1.15 Skeletal Muscle

Relaxant (VI - Anesthesia, Physiology)P-Pharmacology(C+D)/ Pathology(A+B)-

GURU NANAK JAYANTI HOLIDAY

AETCOM Pandemic mod 2.5 Pharmac & Gen Medicine SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

P-Microbiology(C+D)/Pathology(A+B) SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

P-Microbiology(C+D)/Pharmacology(A+B) SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

Clinical Posting

282

08/12/2021 Wednesday L-Microbiology Syphilis(MI7.1/2) SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

283

09/12/2021 Thursday L-Pharmacology PH 1.61 Vitamins SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B)

28410/12/2021 Friday L-Microbiology Viral - Herpes (MI7.1/2)

L-PSM(CM:7.2,Epidemiology of TB I)P-Microbiology (A+B)/Pathology(C+D)


286 12/12/2021 Sunday

287

13/12/2021 MondayL-Pharmacology PH 1.59 Orphan drugs

and counterfit drugs

L-Pathology PA32.2 Describe the etiology, cause,

iodine dependency,

pathogenesis, manifestations, laboratory and

imaging features

and course of thyrotoxicosis VI-GM PHYSIO

PA32.3 Describe the etiology, pathogenesis,

manifestations, laboratory

and imaging features and course of

thyrotoxicosis/

hypothyroidism VI-GM PHYSIO


288

14/12/2021 Tuesday


the epidemiology, etiology, pathogenesis,

pathology, clinical laboratory features,

complications and

progression of diabetes mellitus VI-

PHYSIO GM

L-Pharmacology PH 1.36 Incretin based therapy P-Pharmacology(C+D)/ Pathology(A+B)-

28915/12/2021 Wednesday L-Microbiology Part-End Examination SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

29016/12/2021 Thursday

L-Pharmacology PH 1.57 Drugs used in

skin disorderSGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B)

291

17/12/2021 FridayL-Microbiology Bacterial - Plague

(MI8.1)


FM 3.3 (GEN.SURG.)P-Microbiology(A+B)/Pharmacology(C+D)

292 18/12/2021 Saturday L-Surgery L-Obs & Gynec SPORTS & EXTRACURRICULLAR ACTIVITIES

29319/12/2021 Sunday

294

20/12/2021 MondayL-Pharmacology PH 1.7 Drug induced

disease

L-Pathology PA 33.1 Classify and describe the

etiology, pathogenesis, manifestations,

radiologic and morphologic features and

complications of osteomyelitis VI- ANAT ORTHO


295

21/12/2021 Tuesday

L-Pathology PA 33.2 Classify and


manifestations, radiologic and

morphologic features and

complications and metastases of bone

tumors VI- ORTHO

L-Pharmacology PH 1.22 Drug dependence &

DopingP-Pharmacology(C+D)/ Pathology(A+B)-

296


L-Microbiology Bacteria - Miscellaneous -

Anthrax / Leptospirosis / Rickettsia /

Brucellosis (MI8.1)

SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

29723/12/2021 Thursday


PharmacogenomicsSGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B)

29824/12/2021 Friday L-Microbiology Viral - Rabies (MI8.1)

L-PSM(CM:7.2,TB II)P-Microbiology (A+B)/Pathology(C+D)


300 26/12/2021 Sunday

Clinical Posting

Clinical Posting

Clinical Posting


Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

P-Microbiology(C+D)/Pharmacology(A+B)

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting


301

27/12/2021 Monday P-Microbiology(C+D)/SDL Micro(A+B)


etiology, immunology, pathogenesis,

manifestations, radiologic and laboratory

features, diagnostic

criteria and complications of rheumatoid

arthritis VI-GM


302

28/12/2021 Tuesday

L-Pathology PA34.1 Describe the risk

factors pathogenesis, pathology and

natural

history of squamous cell carcinoma of

the skin

PA34.2 Describe the risk factors

pathogenesis, pathology and natural

history of basal cell carcinoma of the skin

VI-Dermatology,

Venereology &

Leprosy

P-Microbiology (A+B)/SDL Micro(C+D) P-Pharmacology(C+D)/ Pathology(A+B)-

30329/12/2021 Wednesday L-Microbiology Viral - Arbovirus (MI8.1) SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology (A+B)/Pathology(C+D)

30430/12/2021 Thursday P-Microbiology(C+D)/SDL Micro(A+B) SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pathology(A+B)

305

31/12/2021 Friday L-Microbiology Part-End Examination P-Microbiology (A+B)/SDL Micro(C+D) P-Microbiology(A+B)/Pharmacology(C+D)


307 02/01/2022 Sunday

308

03/01/2022 Monday P-Microbiology(C+D)/SDL Micro(A+B)

L-Pathology PA34.3 Describe the distinguishing

features between a nevus and

melanoma. Describe the etiology, pathogenesis,

risk factors

morphology clinical features and metastases of

melanoma VI-Dermatology,

Venereology &

Leprosy


309

04/01/2022 Tuesday


the etiology, genetics, pathogenesis,

pathology, presentation sequelae and

complications of CNS

tumors VI- PAEDIA

P-Microbiology (A+B)/SDL Micro(C+D) P-Pharmacology(C+D)/ Pathology(A+B)-

310

05/01/2022 WednesdayL-Microbiology Opportunistic Infections

(MI8.2)SGD-Pharmacology (A+B)/Pathology (C+D) P-Microbiology(A+B)/Pharmacology(C+D)

311

06/01/2022 Thursday P-Microbiology(C+D)/SDL Micro(A+B) SGD-Pharmacology(C+D)/Pathology (A+B) P-Microbiology(C+D)/Pharmacology(A+B)

31207/01/2022 Friday

L-Microbiology Systemic Mycoses

(MI8.2)P-Microbiology (A+B)/Pathology(C+D)

313 08/01/2022 Saturday L-Surgery L-Obs & Gynec

31409/01/2022 Sunday

315 10/01/2022 Monday

316 11/01/2022 Tuesday

317 12/01/2022 Wednesday

318 13/01/2022 Thursday

319 14/01/2022 Friday

320 15/01/2022 Saturday

321 16/01/2022 Sunday

322 17/01/2022 Monday

323 18/01/2022 Tuesday

324 19/01/2022 Wednesday

325 20/01/2022 Thursday

Clinical Posting

Clinical Posting


Clinical Posting

Clinical Posting

Clinical Posting

P-Microbiology(C+D)/Pharmacology(A+B) SPORTS & EXTRACURRICULLAR ACTIVITIES

Clinical Posting

PREUNIVERSITY EXAMINATION

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

326 21/01/2022 Friday

327 22/01/2022 Saturday

328 23/01/2022 Sunday

329 24/01/2022 Monday

330 25/01/2022 Tuesday

331 26/01/2022 Wednesday

332 27/01/2022 Thursday

333 28/01/2022 Friday

334 29/01/2022 Saturday

335 30/01/2022 Sunday

336 31/01/2022 Monday

337 01/02/2022 Tuesday

338 02/02/2022 Wednesday

339 03/02/2022 Thursday

340 04/02/2022 Friday

341 05/02/2022 Saturday

342 06/02/2022 Sunday

343 07/02/2022 Monday

344 08/02/2022 Tuesday

345 09/02/2022 Wednesday

346 10/02/2022 Thursday

347 11/02/2022 Friday

348 12/02/2022 Saturday

349 13/02/2022 Sunday

350 14/02/2022 Monday

351 15/02/2022 Tuesday

352 16/02/2022 Wednesday

353 17/02/2022 Thursday

354 18/02/2022 Friday

355 19/02/2022 Saturday

356 20/02/2022 Sunday

357 21/02/2022 Monday

358 22/02/2022 Tuesday

359 23/02/2022 Wednesday

360 24/02/2022 Thursday

361 25/02/2022 Friday

362 26/02/2022 Saturday

363 27/02/2022 Sunday

28/02/2022 Monday

PREUNIVERSITY EXAMINATION

UNIVERSITY EXAMINATION

Documents

GMERS MEDICAL COLLEGE, DHARPUR, PATAN, TIME TABLE OF